Target intelligence / Profile preview

microRNA 3160-1 (MIR3160-1)

Target
MIR3160-1
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

microRNA 3160-1 (MIR3160-1) is a human microRNA gene that encodes a small non-coding RNA molecule involved in the regulation of gene expression at the post-transcriptional level. Like other miRNAs, MIR3160-1 is transcribed as a primary transcript (pri-miRNA), processed by the Drosha-DGCR8 complex and further processed by Dicer to yield a mature miRNA duplex. The mature miRNA can then associate with Argonaute proteins to form the RNA-induced silencing complex (RISC), which binds to complementary sequences on target mRNAs, predominantly in the 3'-UTR, causing translational repression or mRNA degradation. The specific physiological or pathological roles of MIR3160-1 have not been well characterized in the literature, and it is not currently a recognized direct therapeutic target or biomarker. There are no drugs reported to interact with this specific miRNA, nor are there validated mechanisms of action for targeting it. Like other miRNAs, MIR3160-1 may participate in fine-tuning gene expression, but disease associations, druggability, and safety considerations have not been established for this individual molecule.

Other names
hsa-mir-3160-1mir-3160-1MIR3160-1
02

Mechanism of action

Not applicable for individual therapeutic agents (for the miRNA family: inhibition of target mRNA translation, mRNA degradation, gene silencing)

03

Biological functions

Gene expression regulationmRNA silencingpost-transcriptional regulation
04

Disease associations

CancerCardiovascular diseasesNeurological diseasesImmune dysregulation
05

Safety considerations

Potential general concerns for miRNA therapeutics include off-target effectsImmune stimulationTissue-specific delivery challenges
06

Biomarkers

miRNAs as a class can be biomarkers in cancers and other diseases

Beyond the preview

Go deeper on microRNA 3160-1 (MIR3160-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 3160-1 (MIR3160-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call